Darunavir (Ethanolate) - CAS# 635728-49-3 2607 Hydrochloride 5-dimethylphenoxy)-2

5-dimethylphenoxy)-2

CN1N=NN=C1SCC1CS[C@@H]2[C@H](NC(=O)[C@H](NC(=O)C3=CN=C(C)C=C3O)C3=CC=C(O)C=C3)C(=O)N2C=1C([O-])=O

hexyl 5-aminolevulinate induces the endogenous production of the photosensitizer protoporphyrin IX (PPIX) which accumulates selectively in tumor tissue

InChiKey: MQNYRKWJSMQECI-QFIPXVFZSA-N

OC(=O)CC1=CC(=CC=C1)OCCCN(CC(C1C=CC=CC=1)C1C=CC=CC=1)CC1=CC=CC(=C1Cl)C(F)(F)F

Darunavir (Ethanolate) - CAS# 635728-49-3 2607 Hydrochloride 5-dimethylphenoxy)-2Darunavir is a drug used to treat HIV infection. It is in the protease inhibitor class. Prezista is an OARAC recommended treatment option for treatment nave and treatment experienced adults and adolescents. Developed by pharmaceutical company Tibotec, darunavir is named after Arun K. Ghosh, the chemist who discovered the molecule at the University of Illinois at Chicago. It was approved by the Food and Drug Administration (FDA) on June 23, 2006. .